SavedAdd your journal

Journals / Medicine Science / 2021 / Cilt: 10 - Sayı: 4

Evaluation of serum perlecan levels in pregnancy with mild and severe preeclampsia

Tufan Arslanca
Muhammed Seyi̇thanoglu
Ugurkan Erkayiran
Abdullah Tok
Seli̇m Karakucuk
Pages
1179–1182
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Perlecan level in group 1 was determined at higher levels than other groups, and this level difference was statistically significant compared to the other two groups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, we aimed to determine the levels of perlecan contributing to autophagy inhibition and angiogenesis in severe and mild preeclamptic women.
📊
Key Findings & Data:A total of 89 patients including severe preeclampsia, group 1 (n:30), mild preeeclampsia, group 2 (n:30) and control group, group 3 (n:29) were included in the study.
💡
Conclusion & Impact:Perlecan level in group 1 was determined at higher levels than other groups, and this level difference was statistically significant compared to the other two groups (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this study, we aimed to determine the levels of perlecan contributing to autophagy inhibition and angiogenesis in severe and mild preeclamptic women. A total of 89 patients including severe preeclampsia, group 1 (n:30), mild preeeclampsia, group 2 (n:30) and control group, group 3 (n:29) were included in the study. All three groups were evaluated in terms of perlecan levels. Perlecan level in group 1 was determined at higher levels than other groups, and this level difference was statistically significant compared to the other two groups (p

🔖

Cite This Article

Arslanca, T., Seyi̇thanoglu, M., Erkayiran, U., Tok, A., Karakucuk, S. (2022). Evaluation of serum perlecan levels in pregnancy with mild and severe preeclampsia. Medicine Science, Cilt: 10 - Sayı: 4, 1179–1182. https://ajindex.com/articles/579627

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. El-Sayed AAF. Preeclampsia: A review of the pathogenesis and possible management strategies based on its pathophysiological derangements. Taiwan J Obstet Gynecol. 2017;56:593-8
  2. Abalos E, Cuesta C, Grosso AL, et al. Global and regional estimates of preeclampsia and eclampsia: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170:1-7
  3. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: The “chickenand-egg” question. Endocrinology. 2004;145:4835-7
  4. Jiang X, Couchman JR. Perlecan and tumor angiogenesis. J Histochem Cytochem. 2003;51:1393-410
  5. Ning L, Xu Z, Furuya N, et al. Perlecan inhibits autophagy to maintain muscle homeostasis in mouse soleus muscle. Matrix Biol. 2015;48:26-35
  6. Gubbiotti MA, Neill T, Iozzo RV. A current view of perlecan in physiology and pathology: A mosaic of functions. Matrix Biol. 2017;57-58:285-98
  7. Vuadens F, Benay C, Crettaz D, et al. Identification of biologic markers of the prematüre rupture of fetal membranes: Proteomic approach. Proteomics. 2003;3:1521-5
  8. Akbas M, Koyuncu FM, Ulkumen BA, et al. Maternal serum perlecan levels in women with preeclampsia. Hypertens Pregnancy. 2020;39:70-6
  9. Szenasi NL, Toth E, Balogh A, et al. Proteomic identification of membraneassociated placental protein 4 (MP4) as perlecan and characterization of its placental expression in normal and pathologic pregnancies. Peer J. 2019;20;7:e6982
  10. Yang WC, Su TH, Yang YC, et al. Altered perlecan expression in placental development and gestational diabetes mellitus. Placenta. 2005;26:780–8
  11. Chui A, Murthi P, Brennecke SP, et al. The expression of placental proteoglycans in pre-eclampsia. Gynecol Obstet Invest. 2012;73:277-84
  12. Zhao H, Gong L, Wu S, et al. The inhibition of protein kinase C β contributes to the pathogenesis of preeclampsia by activating autophagy E Bio Medicine. 2020;56:102813
  13. Du J, Ji Q, Dong L, et al. HDAC4 knockdown induces preeclampsia cell autophagy and apoptosis by miR-29b. Reprod Sci. 2021;28:334-42
  14. Cornelius DC, Wallace K. Autophagy in preeclampsia: A new target? E Bio Medicine. 2020;57:102864
  15. Nakashima A, Aoki A, Kusabiraki T, et al. Autophagy regulation in preeclampsia: Pros and cons. J Reprod Immunol. 2017;123:17-23.